Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance).

Brown JC, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Denlinger CS, Atkins JN, Goldberg RM, Ng K, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA.

JNCI Cancer Spectr. 2019 Oct 17;4(1):pkz078. doi: 10.1093/jncics/pkz078. eCollection 2020 Feb.

PMID:
32259016
2.

Association between biomass fuel use and risk of hypertension among Chinese older people: A cohort study.

Deng Y, Gao Q, Yang D, Hua H, Wang N, Ou F, Liu R, Wu B, Liu Y.

Environ Int. 2020 May;138:105620. doi: 10.1016/j.envint.2020.105620. Epub 2020 Mar 13.

3.

Bayesian machine learning on CALGB/SWOG 80405 (Alliance) and PEAK data identify a heterogeneous landscape of clinical predictors of overall survival (OS) in different populations of metastatic colorectal cancer (mCRC).

Das R, Ou F, Washburn C, Innocenti F, Nixon A, Lenz H, Blanke C, Niedzwiecki D, Khalil I, Harms B, Venook A.

Ann Oncol. 2019 Jul;30 Suppl 4:iv116. doi: 10.1093/annonc/mdz156.019. Epub 2019 Dec 4. No abstract available.

PMID:
32084987
4.

Mutual inhibition between Prkd2 and Bcl6 controls T follicular helper cell differentiation.

Misawa T, SoRelle JA, Choi JH, Yue T, Wang KW, McAlpine W, Wang J, Liu A, Tabeta K, Turer EE, Evers B, Nair-Gill E, Poddar S, Su L, Ou F, Yu L, Russell J, Ludwig S, Zhan X, Hildebrand S, Li X, Tang M, Murray AR, Moresco EMY, Beutler B.

Sci Immunol. 2020 Jan 24;5(43). pii: eaaz0085. doi: 10.1126/sciimmunol.aaz0085.

PMID:
31980486
5.

Distribution, genetic characteristics and public health implications of Triatoma rubrofasciata, the vector of Chagas disease in Guangxi, China.

Shi Y, Wei Y, Feng X, Liu J, Jiang Z, Ou F, Wei H, Lv G, Wan X, Wang Z, Yang Y.

Parasit Vectors. 2020 Jan 20;13(1):33. doi: 10.1186/s13071-020-3903-z.

6.

Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials.

An MW, Tang J, Grothey A, Sargent DJ, Ou FS, Mandrekar SJ.

Contemp Clin Trials Commun. 2019 Nov 22;17:100492. doi: 10.1016/j.conctc.2019.100492. eCollection 2020 Mar.

7.

Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.

Chakrabarti S, Zemla TJ, Ahn DH, Ou FS, Fruth B, Borad MJ, Hartgers ML, Wessling J, Walkes RL, Alberts SR, McWilliams RR, Liu MC, Durgin LM, Bekaii-Saab TS, Mahipal A.

Oncologist. 2019 Dec 11. pii: theoncologist.2019-0874. doi: 10.1634/theoncologist.2019-0874. [Epub ahead of print]

8.

A Tuning Fork Gyroscope with a Polygon-Shaped Vibration Beam.

Xu Q, Hou Z, Kuang Y, Miao T, Ou F, Zhuo M, Xiao D, Wu X.

Micromachines (Basel). 2019 Nov 25;10(12). pii: E813. doi: 10.3390/mi10120813.

9.

Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).

Yuan C, Sato K, Hollis BW, Zhang S, Niedzwiecki D, Ou FS, Chang IW, O'Neil BH, Innocenti F, Lenz HJ, Blanke CD, Goldberg RM, Venook AP, Mayer RJ, Fuchs CS, Meyerhardt JA, Ng K.

Clin Cancer Res. 2019 Dec 15;25(24):7497-7505. doi: 10.1158/1078-0432.CCR-19-0877. Epub 2019 Sep 23.

PMID:
31548349
10.

Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial.

Wei AC, Ou FS, Shi Q, Carrero X, O'Reilly EM, Meyerhardt J, Wolff RA, Kindler HL, Evans DB, Deshpande V, Misdraji J, Tamm E, Sahani D, Moore M, Newman E, Merchant N, Berlin J, Goff LW, Pisters P, Posner MC.

Ann Surg Oncol. 2019 Dec;26(13):4489-4497. doi: 10.1245/s10434-019-07685-1. Epub 2019 Aug 15.

PMID:
31418130
11.

Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.

Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Sato K, Ng K, Van Blarigan E, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA.

J Clin Oncol. 2019 Oct 10;37(29):2620-2631. doi: 10.1200/JCO.19.01019. Epub 2019 Aug 13.

12.

Reply to S. Sorscher.

Innocenti F, Ou FS, Qu X, Zemla T, Niedzwiecki D, Tam R, Mahajan S, Goldberg RM, Bertagnolli MM, Blanke CD, Sanoff H, Atkins J, Polite B, Venook AP, Lenz HJ, Kabbarah O.

J Clin Oncol. 2019 Sep 1;37(25):2291-2293. doi: 10.1200/JCO.19.01366. Epub 2019 Jul 3. No abstract available.

PMID:
31268798
13.

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.

Bekaii-Saab TS, Ou FS, Ahn DH, Boland PM, Ciombor KK, Heying EN, Dockter TJ, Jacobs NL, Pasche BC, Cleary JM, Meyers JP, Desnoyers RJ, McCune JS, Pedersen K, Barzi A, Chiorean EG, Sloan J, Lacouture ME, Lenz HJ, Grothey A.

Lancet Oncol. 2019 Aug;20(8):1070-1082. doi: 10.1016/S1470-2045(19)30272-4. Epub 2019 Jun 28.

PMID:
31262657
14.

Temporomandibular joint disorders contribute to anxiety in BalB/C mice.

Ou F, Su K, Sun J, Zhang Z, Peng Y, Liao G.

Biochem Biophys Res Commun. 2019 Aug 20;516(2):339-343. doi: 10.1016/j.bbrc.2019.06.050. Epub 2019 Jun 14.

PMID:
31208723
15.
16.

Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D3 levels and survival among patients with metastatic colorectal cancer.

Yuan C, Renfro L, Ambadwar PB, Ou FS, McLeod HL, Innocenti F, Meyerhardt JA, Wolpin BM, Goldberg RM, Grothey A, Fuchs CS, Ng K.

Cancer Causes Control. 2019 Jul;30(7):757-765. doi: 10.1007/s10552-019-01183-1. Epub 2019 May 18.

PMID:
31104167
17.

Rapid and cost-effective evaluation of bacterial viability using fluorescence spectroscopy.

Ou F, McGoverin C, Swift S, Vanholsbeeck F.

Anal Bioanal Chem. 2019 Jun;411(16):3653-3663. doi: 10.1007/s00216-019-01848-5. Epub 2019 May 2.

18.

Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance).

Lenz HJ, Ou FS, Venook AP, Hochster HS, Niedzwiecki D, Goldberg RM, Mayer RJ, Bertagnolli MM, Blanke CD, Zemla T, Qu X, Wirapati P, Tejpar S, Innocenti F, Kabbarah O.

J Clin Oncol. 2019 Aug 1;37(22):1876-1885. doi: 10.1200/JCO.18.02258. Epub 2019 May 1. Erratum in: J Clin Oncol. 2020 Feb 20;38(6):656.

19.

Development and validation of a sensitive LC-MS/MS method for the determination of 6-hydroxykynurenic acid in rat plasma and its application to pharmacokinetics study.

Shen Z, He K, Xu M, Zeng K, Pan J, Ou F, Yao J, Wang R, Zeng S.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 15;1116:44-50. doi: 10.1016/j.jchromb.2019.03.033. Epub 2019 Mar 27.

PMID:
30981181
20.

Bead-Based Flow-Cytometric Cell Counting of Live and Dead Bacteria.

Ou F, McGoverin C, White J, Swift S, Vanholsbeeck F.

Methods Mol Biol. 2019;1968:123-134. doi: 10.1007/978-1-4939-9199-0_11.

PMID:
30929211
21.

Dyella dinghuensis sp. nov. and Dyella choica sp. nov., isolated from forest soil.

Ou FH, Gao ZH, Chen MH, Bi JY, Qiu LH.

Int J Syst Evol Microbiol. 2019 May;69(5):1496-1503. doi: 10.1099/ijsem.0.003356. Epub 2019 Mar 22.

PMID:
30900974
22.

Near real-time enumeration of live and dead bacteria using a fibre-based spectroscopic device.

Ou F, McGoverin C, Swift S, Vanholsbeeck F.

Sci Rep. 2019 Mar 18;9(1):4807. doi: 10.1038/s41598-019-41221-1.

23.

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome.

Innocenti F, Ou FS, Qu X, Zemla TJ, Niedzwiecki D, Tam R, Mahajan S, Goldberg RM, Bertagnolli MM, Blanke CD, Sanoff H, Atkins J, Polite B, Venook AP, Lenz HJ, Kabbarah O.

J Clin Oncol. 2019 May 10;37(14):1217-1227. doi: 10.1200/JCO.18.01798. Epub 2019 Mar 13.

PMID:
30865548
24.

Interaction between CYP1A1/CYP17A1 polymorphisms and parental risk factors in the risk of hypospadias in a Chinese population.

Mao Y, Zhang K, Ma L, Yun X, Ou F, Liu G, Yang Y, Zhang Y, Pei X, Duan Z, Ma M.

Sci Rep. 2019 Mar 11;9(1):4123. doi: 10.1038/s41598-019-40755-8.

25.

Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.

Kosumi K, Hamada T, Zhang S, Liu L, da Silva A, Koh H, Twombly TS, Mima K, Morikawa T, Song M, Nowak JA, Nishihara R, Saltz LB, Niedzwiecki D, Ou FS, Zemla T, Mayer RJ, Baba H, Ng K, Giannakis M, Zhang X, Wu K, Giovannucci EL, Chan AT, Fuchs CS, Meyerhardt JA, Ogino S.

Eur J Cancer. 2019 Apr;111:82-93. doi: 10.1016/j.ejca.2019.01.022. Epub 2019 Mar 1.

26.

Milestone prediction for time-to-event endpoint monitoring in clinical trials.

Ou FS, Heller M, Shi Q.

Pharm Stat. 2019 Jul;18(4):433-446. doi: 10.1002/pst.1934. Epub 2019 Feb 26.

27.

Acute corticosterone treatment elicits antidepressant-like actions on the hippocampal 5-HT and the immobility phenotype.

Li Y, Zu Y, Li X, Zhao S, Ou F, Li L, Zhang X, Wang W, He T, Liang Y, Sun X, Tang M.

Brain Res. 2019 Jul 1;1714:166-173. doi: 10.1016/j.brainres.2019.02.022. Epub 2019 Feb 19.

PMID:
30794767
28.

A New Stress-Released Structure to Improve the Temperature Stability of the Butterfly Vibratory Gyroscope.

Ou F, Hou Z, Miao T, Xiao D, Wu X.

Micromachines (Basel). 2019 Jan 24;10(2). pii: E82. doi: 10.3390/mi10020082.

29.

Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance).

Song M, Ou FS, Zemla TJ, Hull MA, Shi Q, Limburg PJ, Alberts SR, Sinicrope FA, Giovannucci EL, Van Blarigan EL, Meyerhardt JA, Chan AT.

Int J Cancer. 2019 Jul 15;145(2):380-389. doi: 10.1002/ijc.32113. Epub 2019 Jan 28.

PMID:
30623420
30.

Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies.

Ou FS, An MW, Ruppert AS, Mandrekar SJ.

JCO Precis Oncol. 2019;3. doi: 10.1200/po.19.00051. Epub 2019 Oct 24.

31.

A viable hypomorphic Arnt2 mutation causes hyperphagic obesity, diabetes and hepatic steatosis.

Turer EE, San Miguel M, Wang KW, McAlpine W, Ou F, Li X, Tang M, Zang Z, Wang J, Hayse B, Evers B, Zhan X, Russell J, Beutler B.

Dis Model Mech. 2018 Dec 18;11(12). pii: dmm035451. doi: 10.1242/dmm.035451.

32.

HDAC10 upregulation contributes to interleukin 1β-mediated inflammatory activation of synovium-derived mesenchymal stem cells in temporomandibular joint.

Liao W, Sun J, Liu W, Li W, Jia J, Ou F, Su K, Zheng Y, Zhang Z, Sun Y.

J Cell Physiol. 2019 Aug;234(8):12646-12662. doi: 10.1002/jcp.27873. Epub 2018 Dec 4.

PMID:
30515817
33.

Analysis and Design of a Polygonal Oblique Beam for the Butterfly Vibratory Gyroscope with Improved Robustness to Fabrication Imperfections.

Ou F, Hou Z, Wu X, Xiao D.

Micromachines (Basel). 2018 Apr 24;9(5). pii: E198. doi: 10.3390/mi9050198.

34.

Indication of Mental Health from Fingertip Pulse Waves and Its Application.

Oyama-Higa M, Ou F.

J Healthc Eng. 2018 Oct 17;2018:7696458. doi: 10.1155/2018/7696458. eCollection 2018. Review.

35.

Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?

Shenoy N, Mudireddy M, Vallapureddy R, Leung N, Pagliaro L, Witzig T, Ou FS, Ordog T, Cheville J, Patnaik M, Thompson RH, Tefferi A, Begna K.

Clin Genitourin Cancer. 2018 Dec;16(6):e1117-e1122. doi: 10.1016/j.clgc.2018.06.008. Epub 2018 Jun 28.

PMID:
30077464
36.

Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance).

Van Blarigan EL, Ou FS, Niedzwiecki D, Zhang S, Fuchs CS, Saltz L, Mayer RJ, Venook A, Ogino S, Song M, Benson A, Hantel A, Atkins JN, Giovannucci EL, Meyerhardt JA.

Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1227-1230. doi: 10.1158/1055-9965.EPI-18-0487. Epub 2018 Jul 23.

37.

Towards Characterization and Adaptive Compensation of Backlash in a Novel Robotic Catheter System for Cardiovascular Interventions.

Omisore OM, Han SP, Ren LX, Wang GS, Ou FL, Li H, Wang L.

IEEE Trans Biomed Circuits Syst. 2018 Aug;12(4):824-838. doi: 10.1109/TBCAS.2018.2825359. Epub 2018 May 15.

PMID:
29994773
38.

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).

Shi Q, Schmitz N, Ou FS, Dixon JG, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Habermann TM, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Coiffier B, Flowers CR.

J Clin Oncol. 2018 Sep 1;36(25):2593-2602. doi: 10.1200/JCO.2018.77.9124. Epub 2018 Jul 5.

39.

Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for regorafenib in refractory metastatic colorectal cancer (mCRC) - An ACCRU Network study.

Bekaii-Saab T, Ou F, Anderson D, Ahn D, Boland P, Ciombor K, Jacobs N, Desnoyers R, Cleary J, Meyers J, Chiorean E, Pedersen K, Barzi A, Sloan J, McCune J, Lacouture M, Lenz H, Grothey A.

Ann Oncol. 2018 Jun;29 Suppl 5:v105. doi: 10.1093/annonc/mdy149.013. Epub 2020 Jan 7. No abstract available.

40.

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J.

Lancet. 2018 May 26;391(10135):2128-2139. doi: 10.1016/S0140-6736(18)30789-X. Epub 2018 May 10.

PMID:
29754777
41.

InP/ZnS QDs exposure induces developmental toxicity in rare minnow (Gobiocypris rarus) embryos.

Chen Y, Yang Y, Ou F, Liu L, Liu XH, Wang ZJ, Jin L.

Environ Toxicol Pharmacol. 2018 Jun;60:28-36. doi: 10.1016/j.etap.2018.04.005. Epub 2018 Apr 5.

PMID:
29655014
42.

A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone.

Wang L, Dehm SM, Hillman DW, Sicotte H, Tan W, Gormley M, Bhargava V, Jimenez R, Xie F, Yin P, Qin S, Quevedo F, Costello BA, Pitot HC, Ho T, Bryce AH, Ye Z, Li Y, Eiken P, Vedell PT, Barman P, McMenomy BP, Atwell TD, Carlson RE, Ellingson M, Eckloff BW, Qin R, Ou F, Hart SN, Huang H, Jen J, Wieben ED, Kalari KR, Weinshilboum RM, Wang L, Kohli M.

Ann Oncol. 2018 Feb 1;29(2):352-360. doi: 10.1093/annonc/mdx689.

43.

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.

Katz MHG, Ou FS, Herman JM, Ahmad SA, Wolpin B, Marsh R, Behr S, Shi Q, Chuong M, Schwartz LH, Frankel W, Collisson E, Koay EJ, Hubbard JM, Leenstra JL, Meyerhardt J, O'Reilly E; Alliance for Clinical Trials on Oncology.

BMC Cancer. 2017 Jul 27;17(1):505. doi: 10.1186/s12885-017-3441-z.

44.

Nationally representative equations that include resistance and reactance for the prediction of percent body fat in Americans.

Stevens J, Truesdale KP, Cai J, Ou FS, Reynolds KR, Heymsfield SB.

Int J Obes (Lond). 2017 Nov;41(11):1669-1675. doi: 10.1038/ijo.2017.167. Epub 2017 Jul 24.

45.

Absolute bacterial cell enumeration using flow cytometry.

Ou F, McGoverin C, Swift S, Vanholsbeeck F.

J Appl Microbiol. 2017 Aug;123(2):464-477. doi: 10.1111/jam.13508. Epub 2017 Jul 13.

PMID:
28600831
46.

The LncRNA ZBED3-AS1 induces chondrogenesis of human synovial fluid mesenchymal stem cells.

Ou F, Su K, Sun J, Liao W, Yao Y, Zheng Y, Zhang Z.

Biochem Biophys Res Commun. 2017 May 27;487(2):457-463. doi: 10.1016/j.bbrc.2017.04.090. Epub 2017 Apr 18.

PMID:
28431932
47.

Quantile Regression Models for Current Status Data.

Ou FS, Zeng D, Cai J.

J Stat Plan Inference. 2016 Nov;178:112-127. Epub 2016 Jul 4.

48.

Aliidongia dinghuensis gen. nov., sp. nov., a poly-β-hydroxybutyrate-producing bacterium isolated from Pinus massoniana forest soil.

Chen MH, Zhou XY, Ou FH, Xia F, Lv YY, Qiu LH.

Int J Syst Evol Microbiol. 2017 Feb;67(2):212-217. doi: 10.1099/ijsem.0.001588. Epub 2017 Feb 21.

PMID:
27902218
49.

A suggested approach for imputation of missing dietary data for young children in daycare.

Stevens J, Ou FS, Truesdale KP, Zeng D, Vaughn AE, Pratt C, Ward DS.

Food Nutr Res. 2015 Dec 17;59:28626. doi: 10.3402/fnr.v59.28626. eCollection 2015.

50.

Prediction of percent body fat measurements in Americans 8 years and older.

Stevens J, Ou FS, Cai J, Heymsfield SB, Truesdale KP.

Int J Obes (Lond). 2016 Apr;40(4):587-94. doi: 10.1038/ijo.2015.231. Epub 2015 Nov 5.

Supplemental Content

Support Center